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Abstract: The primary objective of the study was to explore the effectiveness of Vertebral Axial Decompression (VAX-D) in
treating patients with chronic low back pain (CLBP) as a safe and competent therapeutic method. Also, to determine the
quality of life in alleviating chronic lumbar pain using mechanical Lumbar traction force applied to the lumbar spine. A
systematic review and meta-analysis involving detailed literature survey on Vertebral Axial Decompression (VAX-D) therapy
for patients with chronic low back pain were conducted in three databases namely MEDLINE, EMBASE and Cochrane
Library from (January 1994 to February 2019). Studies supporting the outcomes with qualitative statistical analysis on chronic
low back pain and Lumbar traction were retrieved. We retrieved sixteen randomized controlled trials (RCTs) for systematic
review, and 6 studies were found to be eligible for inclusion in meta-analysis with a sample size of 486 patients receiving
Lumbar traction. Among them, one study was found to be high quality that detailed the positive relationship between reduction
of pain intensity after VAX-D therapy. However, most of the studies are unsuccessful in demonstrating an improvement
towards the patient's mobility or quality of life. There is no reliable indication of the efficacy of VAX-D therapy for chronic
low back pain patients. Studies on VAX-D had methodological errors and inadequate data for profound statistical analysis.
Further, there was no evidence to show the dosage requirement, patient position, and settings on the VAX-D table that led to
observed outcomes. Any prospect of research focusing on LBP morbidity should enable to distinguish between symptom
duration and pattern with accurate standard methods. Therefore, more studies validating the effective treatment strategies in the
management of patients with chronic low back pain are warranted.

Keywords: Vertebral Axial Decompression, Chronic Low Back Pain, Lumbar Traction, Lumbar Spine, Quality of Life,
Randomized Controlled Trials

1. Introduction
Chronic low back (CLBP) exists as one of the significant
causes of disability worldwide. CLBP is a well-recognized
public health burden, and treatment cost has peaked
progressively during four decades. Although there is an
increasing prevalence of CLBP [1], however, their effective
treatment modalities remain elusive. CLBP is experienced by
the illnesses affecting the bony lumbar spine, ligaments

around the backbone and discs, intervertebral discs (discs
between the vertebrae), spinal cord and nerves, muscles of
the low back, internal organs, and the skin covering the
lumbar area. The early LBP is a symptom, not a disease, and
it has a wide range of causes. Chronic LBP was prevalent and
was found to be approximately 84%. In most of the cases,
they are mild to moderate and tentative to repeat without
affecting the daily activities, and thus, the majority of the
individuals with LBP do not seek medical care. In the United
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States, 10-15% of acute LBP becomes chronic; 1% can progresses to permanent disability consuming up to 90% of
health care and social costs for treatment of low back pain
[2]. Despite the acceptance of low back pain disability and
provision of disability benefits for sufferers in society have
significantly contributed to the growing trend of LBP
disability.
CLBP was identified as the third most common cause for
physician visits in males and sixth in females accounting for
6% of all physician visits. One in every three physiotherapist
consultations, 2.5% of drug prescriptions, and 5-10% of
imaging studies were for CLBP [3]. A report from the USA
denoted that approximately 1 in 4 adults face the burden of
low back pain that lasted at least 24 hours within the previous
3 months and about 8% of individuals experience at least one
incidence of severe acute LBP within a year period [4, 5].
Studies conducted on CLBP, reports that around 13% of
work-related injuries result in LBP disability in younger
individuals (< 45 years) and the common leading cause for
sick leaves.
Also, low back pain is the primary cause of inactivity and
unsatisfactory work progress resulting in a vast economic
burden on individuals; families, communities, industry, and
governments’ worldwide [6-9]. In 1998, overall health care
incremental costs were assessed to be $26.2 billion that is
directly attributed to LBP in United States [10].
Lumbar traction is an effective conservative method used
in the treatment of lumbar disc herniation. It is routinely done
by self or in combination with other therapies for the
management of lumbar sciatica [11, 12]. A better relief to
vertebrae separation has been shown by traction technique,
which could provide radicular symptoms relief by directly
removing pressure or forces of contact from affected neural
tissue. It may also have particular benefits by stretching soft
tissues [13].
The mechanisms of action of LT are mediated by
mechanical force through a separation of intervertebral
motion segments [14-16] leading to a substantial decrease in
intradiscal pressure [17-19], and neurophysiological, through
the modulation of the pain pathways by equivalence with
spinal manipulations [20]. Vertebral Axial Decompression
(VAX-D) technique uses significant distractive forces to the
lumbar spine in a graduated, progressive manner using
electric components and an advanced computer control
system [21].
An alternative or additional treatment for secondary
radicular lumbosacral pain to herniation disc is traction. A
motor pulley was designed to provide a segmental
mechanized distraction that resources this sort of nonsurgical
decompression in the spinal region which can be delivered
either in an oscillatory or static fashion for a fixed period.
The elimination of frictional resistance by split table design
between table and patient, and provides manageable,
effective decompression to the spinal region and a noticeable
reduction in intradiscal pressure [21].
Approximately after one month of treatment, only patients
who received VAX-D sessions every alternate day had a

47.4% progress in their pain intensity; with improvements
functionally by 17.7%. After three months, it is further
reduced by 79.4% of their pain intensity, and their
improvements in functional were found to be 50.8%.
However, the proportion of the increase in function and pain
was significantly different in various cases.
A distinct retrospective study also showed benefit with
motorized spinal decompression over standard pelvic
traction [22]. Beattie et al. conducted an 8-week course of
VAX-D and observed significant outcome improvements
for all the post-intervention scores when compared with the
pre-intervention score [23]. Despite these projected
neurologic or/and mechanical mechanisms of action,
currently, there is no clear consensus regarding the amount
of force to apply in LT interventions. In this connection,
popular retrospect articles report mainly that evidence that
is limited or conflicting to support the valuable effect of
Lumbar Traction versus sham or no treatment in patients
with lumbar sciatica [24, 25]. Thus, the outcomes found
from the studies are somewhat problematic to interpret,
given the heterogeneity of levels, modalities, durations of
tractions, treatment duration, and medical status of patients
[26-28].
Cholewicki et al. have reported that antagonistic trunk
muscle co-activation is necessary to provide mechanical
stability to the lumbar spine around a neutral posture that
results in an improved response to increasing the axial load
on the needle [29]. Thus, agonist-antagonist muscle coactivation resulting from vibration therapy might have
improved the patient's motor control strategy to enhance joint
stability and movement accuracy.
Further, traction therapy along with spinal decompression,
can functionally enhance the extension strength in lumbar
and in both dynamic and static balance which are required to
endure a spinal position neutrally. Both vibration and traction
therapy has been associated with reducing pain intensity in
patients with LBP. Recently, Wang et al [30] stated that
traction applied to patients while lying on a table in
combination with 12Hz of vibration was significant in
decreasing muscle fatigue of the lumbar erector spinae.
Six studies were analyzed in groups determined by
similarity of patients, interventions, comparisons, and
outcomes to perform the meta-analysis. This study critically
evaluates data from randomized controlled trials (RCTs)
using VAX-D technique for people with CLBP. The
primary goal of this study is to compile a substantial
amount of peer-reviewed journal articles and provide an
unbiased and non-conflicting perspective on the efficacy of
the VAX-D system.

2. Materials and Methods
An extensive search of scientific articles in reputable peerreviewed journals was done to compile approximately 50
articles. The series of literature searches from January 1994
to February 2019 included using search engines PubMed,
EBSCO multi-search, and Google Scholar electronic
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databases. Keywords used included vertebral axial
decompression, efficacy, lumbar traction, VAX-D, low back
pain, and therapy. Keywords were combined and used to
collect related data. First, abstracts were screened, and if an
item satisfied our inclusion criteria, it was retrieved for full
article use. Additional materials were also extracted by
searching cited references for related content. Manual
searches of insurance company policies regarding VAX-D
coverage were also included. The search was limited to only
published papers in the English language.
2.1. Study Selection
The articles that met our inclusion criteria were prepared
for analysis using Purdue Owl as consultation for writing, as
well as insight into critically dissecting journal articles. To
compare and compile the necessary information for our
systematic review, we examined the following qualities of
each item: blinding of subjects, the method of subject
selection,
experimental
outcomes,
comparison
of
experimental and control groups, and avoidance of bias. A
manual search for additional references was also performed.
Therefore, there could be some publication and language bias
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in the review. Initially, we screened 50 abstracts, but only 23
articles were found to fit our inclusion criteria as outlined in
Table 1. Seven of 23 were disqualified for a variety of
reasons, including: a single case report (n=1), a retrospective
survey (n=1), studies using a machine other than VAX-D
(n=2), an article that was not peer-reviewed (n=1), an opinion
paper (n=1), and a study with no methodology (n=1).
Therefore, we retrieved 16 relevant articles for our literature
analysis. Figure 1 shows the stages of study selection and the
number of studies at each step.
Inclusion criteria contained scientific journal articles
and writings that identified vital elements about the aims
of this systematic review. Participants included in the
analysis were over the age of 18 and had the clinical
diagnosis by a licensed physician and confirmed by
diagnostic imaging of chronic low back pain with or
without radiculopathy or sciatica, herniated disc,
degenerative disc disorder, or facet injury. The study also
had to use at least one of four primary outcomes: pain,
disability index questionnaire, quality of life, and an
overall measurement of improvement.

Figure 1. Flow chart of study selection.
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Exclusion criteria consisted of articles published before
1994 and in languages other than English. Studies that
admitted conflict of interest with the VAX-D company or
involved motorized cervical traction and other methods of
vertebral decompression that were mechanically controlled.

If a study included patients with surgical hardware of the
spine, the use of materials produced by a manufacturer other
than VAX-D, LBP caused by specific pathological origin
(infection, osteoporosis, etc.), or was an isolated case study
were excluded.

Table 1. Characteristics of Selected Studies.
Author and year

Clinical Dx

Beattie et al 2007
[23]

Diagnostic imaging evidence of a
degenerative and/or herniated
intervertebral disk.

Naguszewski et al
2001 [31]

Ramos 2004 [21]
Ramos 2004 [21]
Sherry et al 2001
[32]

Clinical diagnosis of LBP and
unilateral or bilateral L5 or S1
radiculopathy confirmed by CT
or MRI.
Chronic LBP with or without leg
pain, confirmed by MRI or CT
scan.
Disc herniation at one or more
levels confirmed by MRI.
Chronic LBP, associated leg pain,
and Confirmed disc protrusion or
herniation on CT or MRI.

Tilaro et al. 1999
[33]

17 patients with radiculopathy
and abnormal sensory function.

Beattie et al 2007
[23]

Diagnostic imaging evidence of a
degenerative and/or herniated
intervertebral disk.

Naguszewski et al
2001 [31]

Clinical diagnosis of LBP and
unilateral or bilateral L5 or S1
radiculopathy confirmed by CT
or MRI.

Course of Tx
Patients had an eight-week course of prone VAXD treatment consisting of five 30-minute
sessions/week for four weeks, followed by one
30-minute session/week for four additional
weeks.

Additional therapies used with VAX-D

N/A

Treatment sessions varied from 10 to 35 minutes.

Bilateral lower extremity dermatomal
somatosensory evoked potentials
(DSSEPs).

15 distraction and relaxation cycles per day five
days/week for either two or four weeks.

Medication allowed as needed. All other
treatment was stopped.

Measuring intradiscal pressure by inserting the
cannula into the nucleus pulposus of the disc
30-minute treatment session, 15 cycles of
decompression/relaxation, 5 days/week for 4
weeks.
Present Perception Threshold evaluations on 22
nerves of peripheral were taken after and before
VAX-D.
Patients had an eight-week course of prone VAXD treatment consisting of five 30-minute
sessions/week for four weeks, followed by one
30-minute session/week for four additional
weeks.
Treatment sessions varied from 10 to 35 minutes.

Not indicated.
Non-narcotic pain relievers, no PT,
injections or any other treatments allowed.
Unknown

N/A

Bilateral lower extremity dermatomal
somatosensory evoked potentials
(DSSEPs).

Table 1. Continued.
Author and year

Results

Beattie et al 2007
[23]

250/296 patients (84.4%) completed treatment.
Of the subjects that completed the full 24
visits, 247 patients (83.4%) followed up at 30
days and 241 (81.5%) at 180 days.

Naguszewski et al
2001 [31]

Ramos 2004 [21]

Ramos 2004 [21]
Sherry et al 2001
[32]
Tilaro et al. 1999
[33]
Beattie et al 2007
[23]

The average pain reduction was 77%. All
patients had at least 50% improvement in LBP
and radicular symptoms. Complete resolution
of symptoms was observed in 3 patients.
Patients receiving the 20 sessions had a
statistically significant remission of pain
compared to the 10-session group.
VAX-D reduced intradiscal pressure
significantly. Decompression shows an inverse
relationship to tension applied.
At 6-month follow-up, 70% of VAX-D group
showed a sustained success.
14/22 that is (64%) of nerves obtained to
regular function, (27%) that is 6/22 enhanced,
with no improvement towards (4.5%) that is
1/22 and (4.5%) that is 1/22 was worse.
250/296 patients (84.4%) completed treatment.
Of the subjects that completed the full 24

Limitations
This was a prospective, longitudinal
case series study, not a randomized
control trial. Due to weather constraints,
not all the subjects attended all 24
therapy sessions. They did not observe
spinal nerve compression.
Small sample size. Unsure if positive
results are due to a placebo effect. No
long-term effects.
Does not address efficacy, only doseresponse. Patients not randomized;
controls were minimal.
Small patient size. Difficult to a base
physiological effect.
Small sample size, lack of blinding.
Possible nocebo effect.

Patient pain outcomes not measured.
This was a prospective, longitudinal
case series study, not a randomized

Conclusions
Treatment with VAX-D for eight
weeks showed a decrease in pain
intensity (RMDQ) at discharge and
at the 30- and 180-day follow-up
period.
17/28 nerve root responses showed
improvement after VAX-D therapy.
VAX-D achieves best results when
used for 20 daily sessions 5 days
per week.
It is likely to reduce pressure in the
pulpous nucleus of lumbar herniated
discs to levels below 0 mmHg.
VAX-D can achieve statistically
significant improvement in pain and
functional outcome.
VAX-D is proficient of influencing
dysfunction associated with nerve
sensory with compressive
radiculopathy.
Treatment with VAX-D for eight
weeks showed a decrease in pain
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Author and year

Naguszewski et al
2001 [31]

Results
visits, 247 patients (83.4%) followed up at 30
days and 241 (81.5%) at 180 days.

The average pain reduction was 77%. All
patients had at least 50% improvement in LBP
and radicular symptoms. Complete resolution
of symptoms was observed in 3 patients.

Limitations
control trial. Due to weather constraints,
not all the subjects attended all 24
therapy sessions. They did not observe
spinal nerve compression.
Small sample size. Unsure if positive
results are due to a placebo effect. No
long-term effects.
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Conclusions
intensity (RMDQ) at discharge and
at the 30- and 180-day follow-up
period.

17/28 nerve root responses showed
improvement after VAX-D therapy.

Abbreviations: N/A, not available; Tx, Treatment; Dx, Diagnosis. Only articles that were primary research articles were included. Systematic reviews did not
appear in this table.

2.2. Meta-Analysis
Meta-analysis was performed in Review Manager
(RevMan) [Computer program] Version 5.3 using the usercontributed commands forest plot and funnel plot.
Standardized mean differences (SMDs) and subsequent
Odd’s ratio (OR) were calculated for studies that are included
using standard deviations, means, and sample sizes reported
in the relevant publications. A negative SMD relates to a
score with lower back pain being associated with the group.
2.3. Post Hoc Sensitivity Analysis
Effective evaluations were pooled using random model
effects. Unlike fixed model effects, which assume that every
study evaluates the same size effect, a random model effect
considers that every study evaluates a diverse effect. The data
presented in our study were drawn from a particular common
distribution. Additionally, random sampling error, variances
could also be due to differences between study designs and
populations. The I2 statistic was also considered, which
evaluates inconsistency between proximity and is
independent of the size sample.
The inclusion depends on only the studies reporting results
at initial follow-up and the last follow-up time points as a
comparison in the primary analysis. However, to maximize
the comparability, the studies included were used to test the
intensity of pain measured after VAX-D treatment (between
reduced pain Vs. increased pain). One sensitivity analysis
included only studies which collected pain measurements
immediately post-treatment. While other sensitivity analyses
as being at a high RoB were considered with the effect of
included studies.

3. Results
The search strategy initially identified 50 studies, 27 of
which were excluded when limits were applied (clinical trials
with humans, full-text English or Spanish language, and
exceeds selected years). The residual 23 articles were
reviewed; of these, 14 were excluded for being duplicated.
Seven of 23 were disqualified for a variety of reasons,
including: a single case report (n=1), a retrospective survey
(n=1), studies using a machine other than VAX-D (n=2), an
article that was not peer-reviewed (n=1), an opinion paper
(n=1), and a study with no methodology (n=1). Therefore, 16
relevant articles were used in our literature analysis. Finally,

16 articles were found to satisfactory and had an adequate
methodological quality and were consequently selected for
the review and analysis of their results and conclusions. The
procedure of the investigation is summarized in Figure 1.
3.1. Risk of Bias
All the trials contained in our study were randomizedcontrolled parallel studies. The method of randomization was
reported in five trials [21, 23, 32, 33]. Beattie et al [23] study
determined short- and long-term outcomes by using the
VAX-D protocol after administration of prone traction. The
method was applied to a sample of patients with activitylimiting LBP that had been refractory to at least two sessions
of previous, non-operative interventions, with a lack of
randomized clinical trials.
Naguszewski et al [31] study used dermatomal
somatosensory suggested potentials (DSSEPs) to determine
lumbar root decompression following VAX-D therapy. The
selected subjects are DSSEPs satisfied patients undergoing
lumbar spine surgery and the randomized trial was not sensed
in this study. However, the intervention and other follow-ups
were suitable for this analysis. The Ramos [21] study
compared the effects of two dosage regimens of VAX-D
treatments (low and high) on the analogue scale for low back
pain in patients. The study was a prospective randomized
control trial conducted on CLBP patients advised to seek
neurosurgical care after failing standard medical therapy.
Sherry et al [32] conducted a randomized controlled trial that
made attempts to address the question of appropriateness and
efficacy of vertebral axial decompression (VAX-D) therapy.
Tilaro [33] study proposed to determine whether VAX-D
therapy could externally decompress the nerve root, with a
randomized controlled trial between surgically and
conservatively treated patients.
All the five studies included in the analysis reported the
time of follow-up; three studies have eight weeks course of
lumbar traction [23, 31, 33] one reported for 4-6 weeks [32],
and other study reported 6-12 weeks [21] For each included
study, the outcomes listed in the methods section were all
reported. Notable publication bias can be observed since
most of the included and excluded studies were published in
English or Chinese, although we have attempted to do our
best to search all probable literature without any language
restrictions and have contacted investigators to get more
information. The studies included used different range of cutoff times to a particular intensity of pain although it was
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clearly stated that pain was persisting, or recurring, at the site
of shingles at least. We have not restricted to include the
studies using the same definition in order not to introduce
more missing data. One (Sherry et al [32]) of the trials were
rated as at low risk of bias, one (Naguszewski et al [31]) as
high risk of bias, and another two (Ramos [21]; Tilaro [33])
has an unclear risk of bias (Figure 2).
3.2. Results from the Pain Outcome Measures (Reduced
Pain Vs. Increased Pain)
Sherry et al [32] study, a high-quality RCT involving
traction was found to have statistically significant differences
on measures of pain, overall improvement with the duration
of follow-up ranging from 1 to 8 weeks. Duration of LBP in
patients was observed for 6 months (chronic) in Beattie et al
[23], for >3 months (sub-acute and chronic) in Sherry et al
[32] studies. Six studies have been analyzed to determine the

pain outcome measures after VAX-D treatment. Five studies
reported the outcome of post-treatment improvement with
standard mean groups showing lower levels of pain during
follow-up. One of the reviews of Ramos [21] reporting low
dosage group showed improvement in pain relief and found
to be reduced when compared to the high dosage group.
The analysis of Beattie et al [23] showed significant
improvements for all post-intervention outcome scores when
compared with pre-intervention scores (p<0.01). In
Naguszewski et al [31] study, the overall measure of pain
from seven patients displayed significant improvement in
post-treatment after VAX-D therapy for six studies and the
random-effects model was 2.22 (95% CI, 0.69 to 7.13),
corresponding to a reduction in pain among participants at
follow-up (Figure 3). Analysis of I2 statics suggests
inadequate evidence against the assumption of homogeneity
between effect estimates (I2=91%, p=0.18).

Comparison of groups underwent VAX-D therapy to determine pain intensity.
Figure 2. Analysis 1: Forest plot.

Comparison of groups underwent VAX-D therapy to determine pain intensity.
Figure 3. Analysis 2.1 Funnel plot.
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3.3. Pain Intensity Measurement Immediately After VAX-D
Treatment
The three trials, Sherry et al [32]; Tilaro [33] and Beattie et
al [23] involved traction. Beattie et al [23] trial involving
VAX-D suggested a favorable association between the prone
friction applied and VAX-D from the preliminary outcome
measures used in this study (Figure 4). However, the study is
deficient of a randomized control group, and thereby, it is not
possible to establish a relationship between the traction
applied with VAX-D and outcome. In Sherry et al [32] study,
all the VAX-D group patients were recorded with some
improvement in their pain levels, seven (70%) have shown
sustained success (i.e., they still meet the criteria for the
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successful outcome).
From Tilaro [33] study, the overall improvement was 67%
that is statistically significant (p<0.05) since the study
evaluated VAX-D therapy outcome with regards to CPT
score of normal nerve functioning. According to the study,
Sixty-four percent (64%) of the patients achieved complete
recovery of neurologic function, and it was found that risk
ratio of 0.04 (95% CI, 0.00 to 0.58) significantly greater than
the previously reported study. The overall pain intensity
measurement immediately after VAX-D treatment from the
three studies showed significant improvement from lower
back pain with I2 statistic=0%, P=0.51, and the test for
overall effect Z=4.22 (Figure 5).

Comparison of groups’ pain intensity with pain measurement immediately after VAX-D treatment.
Figure 4. Analysis 2: Forest plot.

Comparison of groups’ pain intensity with pain measurement immediately after VAX-D treatment.
Figure 5. Analysis 2: Funnel plot.

3.4. Pain Intensity Measurement During Follow-up After
VAX-D Treatment
All the five trials Sherry et al [32]; Naguszewski et al

[31]; Ramos [21] (Low dosage); Ramos [21] (High dosage);
Beattie et al [23] involved traction with a follow-up for pain
intensity measurement. From Naguszewski et al [31] study,
the majority of the patients recovered from lower back pain
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after 10-20 VAX-D sessions or therapy, and the analysis
showed randomized risk ratio of 0.17 (95% 0.03 to 1.05). In
Ramos [21] study, one set of patients obtained an average
course of treatment consisting of 18 regular sessions, and
another group obtained half the number of daily treatment
sessions. The treatment parameters for all the patients
differed only in terms of the number of sessions while the

outcome differed for two groups and found that 67% of the
higher dosage group attained remission of low back pain
compared to 43% of the lower dosage group. The overall
static I2 was found to be 92% with an odd’s ratio of 0.56
(95% CI, 0.37 to 0.85). This analysis is seen in Figures 6
and 7.

Comparison of groups’ pain intensity with pain measurement during follow-up after VAX-D treatment.
Figure 6. Analysis 3: Forest Plot.

Comparison of groups’ pain intensity with pain measurement during follow-up after VAX-D treatment.
Figure 7. Analysis 3: Funnel plot.

3.5. Adverse Events
None of the studies reported about adverse events.

4. Discussion
In our review, we have determined to use qualitative
analysis since many studies failed to provide sufficient data
for statistical pooling. It impacts to have false-positive
findings with several methodological weaknesses. From this
analysis, we observed some conflicting results regarding the
effectiveness of VAX-D traction treatment in patients with

lower back pain. Our main findings of the study suggest that
VAX-D traction for LBP in patients has provided
improvement or quality of relief after several sessions of
treatment. Beattie et al [23] study was unable to demonstrate
the pattern of pain among patients involved in litigation or
those receiving compression could be managed using VAXD. The researchers duly noted this generalized limitation.
Clinicians administered the sessions as per the VAX-D
protocol and no risk of intervention bias. The type of audit
conducted was not disclosed, and therefore, there could be
some loss to follow-up bias.
In Ramos [21] study, there was no randomization in the
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assignment of participants and activities of daily living were
assessed. Also, no data was available on any loss of patients
to follow up, and it is difficult to assess the possibility of loss
to follow-up bias. The study was more concerned with
understanding the mechanism of therapeutic action as
opposed to demonstrating the efficacy and safety of VAX-D
in treating low back pain.
Sherry et al [32] study reported positive outcomes of posttreatment between VAX-D traction and TENS group of
patients. The study has randomization and blinding to
minimize bias, but the researchers have noted some difficulty
in blinding since the placebo had some effects. The study had
excluded only four patients from the original sample and
observed the minimal possibility of loss to follow-up bias.
This overview described the VAX-D therapy machine and
how it was used, and a comparison between VAX-D and
traction was made. The overview noted the absence of data
on the effectiveness of conventional traction in reducing
intradiscal pressure.
Tilaro [33] study, a non-randomized retrospective
analysis recorded the patient data. The researchers have
appealed that patients have achieved some pain relief
without any data, and there was no supporting evidence to
state a conclusion on the efficacy of VAX-D in back pain
relief. Thus, the report concluded the effectiveness of
VAX-D in disc decompression. In this review, we lack
robust and consistent evidence regarding the use of
traction due to the lack of high-quality studies, the
heterogeneity of study populations, and lack of power.
Some other studies included hospitalized patients with
demonstrated herniated discs, neurological findings, and
back pain. Also, some seemed to have had sample sizes
that were too small to detect a clinically significant
difference. The literature review conveys firmly negative
conclusion on traction, in a generalized sense, it is not an
effective treatment for LBP patients.

technique in the treatment of chronic low back pain patients
are warranted.
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